%0 Journal Article %T Chemerin与多囊卵巢综合征的关系及可能作用机制
The Association of Polycystic Ovary Syndrome between Chemerin and Its Possible Mechanism %A 何咏茹 %A 刘东方 %J Journal of Clinical Personalized Medicine %P 580-585 %@ 2334-3443 %D 2025 %I Hans Publishing %R 10.12677/jcpm.2025.41084 %X 多囊卵巢综合征(PCOS)作为育龄期女性常见的内分泌疾病,其人群中脂肪因子被不断研究,如脂联素等在正常女性中的循环水平与PCOS人群具有差异性。随着PCOS的相关研究越来越深入,Chemerin作为一种脂肪因子与PCOS有复杂的联系。本文就Chemerin在PCOS中的研究进展进行综述,旨在为Chemerin在PCOS的进一步研究中提出新的见解,为了解和治疗PCOS提供新的思路。
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder among women of reproductive age and has been extensively studied in the context of adipokine dysregulation. Among these adipokines, lipocalin demonstrates distinct circulating levels in PCOS patients compared to non-PCOS individuals. As research on PCOS advances, Chemerin, a multifunctional adipokine, has gained increasing attention due to its potential role in the pathophysiology of PCOS. This article reviews the current research progress on Chemerin in PCOS, aiming to provide novel insights for future investigations and to explore potential therapeutic strategies for PCOS management. %K 多囊卵巢综合征, %K Chemerin, %K 脂肪因子, %K 胰岛素抵抗, %K 综述
Polycystic Ovary Syndrome %K Chemerin %K Adipokine %K Insulin Resistance %K Review %U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=107901